Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) EBT Margin (2016 - 2025)

Macrogenics (MGNX) has disclosed EBT Margin for 14 consecutive years, with 36.22% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 3.0% to 36.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51.49% through Dec 2025, down 936.0% year-over-year, with the annual reading at 50.36% for FY2025, 634.0% down from the prior year.
  • EBT Margin for Q4 2025 was 36.22% at Macrogenics, down from 23.09% in the prior quarter.
  • The five-year high for EBT Margin was 50.86% in Q3 2024, with the low at 1686.79% in Q2 2024.
  • Average EBT Margin over 5 years is 303.66%, with a median of 233.19% recorded in 2021.
  • The sharpest move saw EBT Margin plummeted -133861bps in 2024, then skyrocketed 152427bps in 2025.
  • Over 5 years, EBT Margin stood at 411.65% in 2021, then skyrocketed by 104bps to 16.39% in 2022, then plummeted by -2908bps to 460.39% in 2023, then soared by 92bps to 36.19% in 2024, then fell by 0bps to 36.22% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 36.22%, 23.09%, and 162.52% for Q4 2025, Q3 2025, and Q2 2025 respectively.